CERRX

cerrx-logo

CerRx Inc. engages in the discovery and development of anticancer drugs for cancer patients. Its products include Fenretinide, a synthetic molecule that increases ceramide waxes and kills cancer cells; and Safingol, an artificial ceramide precursor that increases killing of fenretinide in cancer cells. The company was founded in 2008 and is based in Lubbock, Texas.

#SimilarOrganizations #People #Website #More

CERRX

Industry:
Biotechnology Health Care Medical

Founded:
2008-01-01

Address:
Lubbock, Texas, United States

Country:
United States

Website Url:
http://www.cerrx.com

Total Employee:
1+

Status:
Active

Contact:
806-780-6068

Email Addresses:
[email protected]

Total Funding:
2.13 M USD

Technology used in webpage:
Apache


Similar Organizations

idera-pharmaceuticals-logo

Idera Pharmaceuticals

Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.

illumina-logo

Illumina

Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function.

Current Employees Featured

not_available_image

Richard L. Love
Richard L. Love Chief Executive Officer @ CerRx
Chief Executive Officer

not_available_image

C. Patrick Reynolds
C. Patrick Reynolds Chief Scientific Officer @ CerRx
Chief Scientific Officer

not_available_image

Barry J. Maurer
Barry J. Maurer Chief Medical Officer @ CerRx
Chief Medical Officer

Founder


not_available_image

Barry J. Maurer

Official Site Inspections

http://www.cerrx.com

  • Host name: 172.67.171.234
  • IP address: 172.67.171.234
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "CerRx" on Search Engine

CerRx - Crunchbase Company Profile & Funding

Operating Status Active. Last Funding Type Venture - Series Unknown. Company Type For Profit. Contact Email [email protected]. Phone Number 806-780-6068. CerRx Inc. engages in the discovery and development of anticancer drugs for cancer patients. Its products include Fenretinide, a synthetic molecule that increases ceramide waxes and โ€ฆSee details»

CerRx Company Profile - Office Locations, Competitors, Revenue โ€ฆ

CerRx is an anticancer drug discovery and development company. It offers Fenretinide, a synthetic molecule that increases ceramide waxes and kills cancer cells; and Safingol, an artificial ceramide precursor that increases killing of fenretinide in cancer cells.See details»

CerRx Company Profile 2024: Valuation, Funding & Investors

Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most. Information on valuation, funding, cap tables, investors, and executives for CerRx. Use the PitchBook Platform to explore the full profile.See details»

CerRx CEO and Key Executive Team | Craft.co

Richard L. Love. Executive Chairman of the Board. Barry J. Maurer. Chief Medical Officer and Acting Chief Executive Officer. C. Patrick Reynolds. Chief Scientific Officer. Report incorrect company information. Key Executive Tracking. Receive notifications of key executive changes. Get started. Executives of similar companies. Spirita Oncology.See details»

CerRx - Products, Competitors, Financials, Employees, โ€ฆ

Mar 30, 2024 CerRx is an intermediate stage, targeted anticancer drug discovery and development company. The flagship in the CerRx pipeline is the intravenous (emulsion) fenretinide (4-HPR) formulation (patents issued and licensed to CerRx). Phase II studies of intravenous emulsion fenretinide are being planned with the National Cancer Institute โ€ฆSee details»

CerRx - Company Profile - Tracxn

Apr 8, 2024 CerRx is an intermediate stage biopharmaceutical company engaged in the discovery and development of anticancer drugs for cancer patients.See details»

Barry J. Maurer - Chief Medical Officer @ CerRx - Crunchbase

Primary Organization. CerRx. Gender Male. Dr. Maurer is an outstanding bench-to-the-bedside physician-scientist, who is the Program Leader, Developmental Therapeutics Program, Texas Tech University Health Science Center School of Medicine (TTUHSC SOM) Cancer Center.See details»

CerRx, Inc. Secures World-Wide Exclusive License from John ... - BioSpace

Apr 30, 2009 CerRx, Inc. Secures World-Wide Exclusive License from John Wayne Cancer Institute and Children's Hospital Los Angeles on New Formulation of Vitamin A Analog to Treat Cancer - read this article along with other careers information, tips and advice on BioSpace.See details»

CerRx - Contacts, Employees, Board Members, Advisors

Barry J. Maurer Chief Medical Officer. Unlock even more features with Crunchbase Pro. Start Your Free Trial. CerRx engages in the discovery and development of anticancer drugs such as Fenretinide and Safingol.See details»

New Oncology Developer Ascalon International Inc. Announces โ€ฆ

Jun 4, 2010 SCOTTSDALE, Ariz., June 3 /PRNewswire/ -- Ascalon International Inc., a newly established oncology drug developer, today announced an agreement for an exclusive option to license CerRx Inc's...See details»

CP130023 โ€” Cancer Prevention and Research Institute of Texas

Grant Information. Texans voted in 2007 to create the Cancer Prevention & Research Institute of Texas (CPRIT) and to invest $3 billion in the stateโ€™s unprecedented fight against cancer.See details»

CERRX, INC. | VentureRadar

Nov 5, 2018 VentureRadar profile. Find out more about CERRX, INC. including the VentureRadar Innovation and Growth scores, Similar Companies and more.See details»

New Oncology Developer Ascalon International Inc. Announces โ€ฆ

Jun 4, 2010 SCOTTSDALE, Ariz., June 3 /PRNewswire/ -- Ascalon International Inc., a newly established oncology drug developer, today announced an agreement for an exclusive option to license CerRx Inc's intravenous (IV) fenretinide (4-HPR) product.See details»

CerRx - Funding, Financials, Valuation & Investors - Crunchbase

Organization. CerRx. Connect to CRM. Save. Summary Financials People Technology Signals & News Similar Companies. Highlights. Funding Rounds 1. Total Funding Amount. Unlock for free. Funding. CerRx has raised a total of. $2.1M. in funding over 1 round. This was a Venture - Series Unknown round raised on Feb 4, 2013. Unlock for free. Funding โ€ฆSee details»

Organization | CerRx, Inc. - CDEK

CerRx, Inc. Report issue. For profit Phase 2. Founded: Lubbock TX United States (2008 ... Organization Overview. First Clinical Trial. 2016 NCT02495415. First Marketed Drug. None First NDA Approval. None ...See details»

CER โ€“ Organization and Structure

CER โ€“ Organization and Structure. Home. About Us. Who we are and what we do. Organization and Structure. The CER is structured into business units, reflecting major areas of responsibility. Board of Directors. Indigenous Advisory Committee. Commissioners. CEO. Chief of Staff. Vice President, Secretary of the Commission.See details»

Cerrx

Dec 1, 2023 March 4, 2024 by Bruce Watkins. Menstruation is a natural biological process that signifies the shedding of the uterine lining in the absence of pregnancy. While the experience of menstruation varies widely among individuals, the occurrence of blood clots during periods is a common phenomenon that can raise questions and concerns. These โ€ฆSee details»

CERRX, INC. | SBIR.gov

Company Information. Address. 3911 4TH ST. LUBBOCK, TX 79409-9805. United States. http://www.cerrx.com. Information. UEI: N/A. # of Employees: 4. Ownership Information. HUBZone Owned: No. Socially and Economically โ€ฆSee details»

Computer emergency response team - Wikipedia

Computer emergency response team. A computer emergency response team ( CERT) is an expert group that handles computer security incidents. Alternative names for such groups include cyber emergency response team, computer emergency readiness team, and computer security incident response team ( CSIRT ).See details»

Fenretinide intravenous - CerRx - AdisInsight - Springer

Contact your organizationโ€™s admin about adding this content to your AdisInsight subscription. Buy a PDF version of the profile. Request a free trial. CerRx is developing an intravenous emulsion formulation of fenretinide for the treatment of cancer, including solid tumours and lymphoma. Fenretinide is a.See details»